PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Atropine sulfate - Uveitis

PAD Profile : Atropine sulfate - Uveitis

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Eye drops
  • Eye drops (preservative free, unit dose)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
05 September 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Prescribing Clinical Network recommends the use of Atropine for the treatment of licensed hospital indications ( including Iritis and Uveitis)

Atropine will be considered to be RED on the traffic light system.

New patients:

·         Should be initiated on Atropine 1% minims® by their consultant ophthalmologist 

·         Patients with manual dexterity issues can be initiated on Atropine 1% eye drop (bottles)

Switching patients from Atropine 1% eye drops (bottles):

Patients currently using Atropine 1% eye drops for licensed indications who do not have manual dexterity issues, should be switched to Atropine 1% minims® at their next medication review.

Associated BNF Codes

11. Eye
11.05.00. Mydriatics and cycloplegics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More